K
Kazia Therapeutics Limited D
D
KZIA
3.85000
USD
0.05
(1.32%)
مغلق
حجم التداول
1,467
الربح لكل سهم
-41
العائد الربحي
-
P/E
-0
حجم السوق
4,303,757
الأخبار المقالات
العنوان: Kazia Therapeutics Limited
القطاع: Healthcare
الصناعة: Biotechnology
Kazia Therapeutics Ltd is an oncology-focused biotechnology company, developing anti-cancer drugs. The group is developing paxalisib, a potential treatment for glioblastoma; Cantrixil, being developed for the treatment of ovarian cancer; and Others. The company is also developing EVT801 for the treatment of various tumors. Maximum of revenue is earned from South Korea.